Baxter International Inc. (BAX) vs BridgeBio Pharma, Inc. (BBIO)
A side-by-side comparison of Baxter International Inc. and BridgeBio Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BAX
Baxter International Inc.
$24.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BBIO
BridgeBio Pharma, Inc.
$66.14HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BAX vs BBIO
growth of $100 · dividends reinvested · last 7yBAX -66.0% (-14.3%/yr)BBIO +140.1% (+13.3%/yr)BBIO compounded faster over this window
Log scale — wide-divergence pair
BAX BBIO
BAX vs BBIO: by the numbers
- •BBIO is the larger company ($12.95B vs $12.52B market cap).
- •Both run net losses; BAX's is the smaller (-9.27% vs -97.64% net margin).
- •BBIO grew revenue faster over the past five years (62.61% vs -1.22% CAGR).
- •BAX pays a dividend (0.17% yield), while BBIO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BAX | BBIO |
|---|---|---|
| Forward P/E | 11.79 | N/A |
| P/S ratio | 1.09 | 18.17 |
| P/B ratio | 2.02 | N/A |
| EV / EBITDA | 29.51 | N/A |
| FCF yield | 5.41% | N/A |
Profitability
| Metric | BAX | BBIO |
|---|---|---|
| Gross margin | 30.08% | 93.35% |
| Operating margin | -2.39% | -113.35% |
| Net margin | -9.27% | -97.64% |
| ROE | -17.13% | N/A |
| ROIC | -1.61% | -62.14% |
Dividends
| Metric | BAX | BBIO |
|---|---|---|
| Dividend yield | 0.17% | N/A |
Growth (annualized)
| Metric | BAX | BBIO |
|---|---|---|
| Revenue CAGR (5Y) | -1.22% | 62.61% |
| FCF CAGR (5Y) | -12.92% | N/A |
| Total return CAGR (5Y) | -19.87% | 7.38% |
Frequently asked
- Which has grown faster, BAX or BBIO?
- Over the past five years, BBIO grew revenue faster — BAX at a -1.22% CAGR versus BBIO at 62.61%.
- Does BAX or BBIO pay a bigger dividend?
- BAX pays a dividend (0.17% yield), while BBIO has no payments in the available dividend history.
- How have BAX and BBIO total returns compared?
- Over the past 5 years, BAX delivered -19.87% and BBIO delivered 7.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Baxter International dividend yieldBaxter International ROEBridgeBio Pharma ROEBaxter International operating marginBridgeBio Pharma operating marginBaxter International revenue growthBridgeBio Pharma revenue growthBaxter International free cash flowBridgeBio Pharma free cash flow
Baxter International & BridgeBio Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.